Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery

Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Feb 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how well patients recover after having knee replacement surgery, specifically focusing on those who receive a special type of pain relief called an adductor canal block. The goal is to see how many patients can safely leave the hospital within two days after their surgery and participate in an Accelerated Rehabilitation Program. To be eligible for the trial, participants should be adults between the ages of 65 and 75, undergoing their first knee replacement surgery for osteoarthritis, and willing to follow the recovery plan after surgery.

Participants in the trial can expect to be closely monitored during their recovery, with specific goals set for their mobility and overall health before being discharged from the hospital. To ensure safety, there are certain conditions that would exclude someone from participating, such as having previous knee surgery, certain health issues, or being unable to walk before the surgery. It's important to know that all participants will need to sign a consent form to take part in the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with a score "American Society of Anesthesiologists" I to III;
• • Patient undergoing initial unilateral prosthetic knee replacement surgery for osteoarthritis;
• • Patient eligible for analgesia by block of the adductor canal associated with additional infiltration;
• • Patient accepting to follow the enhanced recovery program after surgery;
• • Patient who signed an informed consent form to participate in the study.
• Exclusion Criteria:
• • Patient with a known allergy to a study product;
• • Patient having undergone previous surgery with a prosthesis on the knee to be operated on;
• • Patient with morbid obesity (Body Mass Index \> 40);
• • Patient with a pre-existing inability to walk;
• • Patient with a history of chronic neuropathic pain in the leg undergoing surgery;
• • Patient with heart failure with impaired ejection fraction;
• • Patient with a history of drug addiction;
• • Patient chronically taking level III analgesics;
• • Patient taking gabapentin or pregabalin chronically;
• • Patient with severe renal or hepatic impairment;
• • Patient with a high level of dependence, defined by level 1 or 2 of the Iso-Ressources Group;
• • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
• • Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
• • Pregnant or likely to be pregnant (of childbearing age without effective contraception) or breastfeeding;
• • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
• • Patient not benefiting from a social security scheme.